Viewpoints
Viewpoints
Jerald Radich, MDViewpoints | November 23, 2022
Jerald Radich, MD; and Christopher S. Hourigan, MD, DPhil, FACP, FRCP; discuss minimal residual disease.
Read More
Leah SherwoodAcute Myeloid Leukemia | October 21, 2022
Marina Konopleva, MD, PhD, discusses venetoclax resistance in AML during SOHO 2022
Cecilia BrownAcute Myeloid Leukemia | October 13, 2022
Marina Konopleva, MD, PhD, discusses her new role at the Albert Einstein College of Medicine and highlights from her career ...
Cecilia BrownMyeloma | October 13, 2022
We are entering the great era of immunotherapy in multiple myeloma, as we’ve had significant...
Leah SherwoodChronic Myeloid Leukemia | September 27, 2022
International Chronic Myeloid Leukemia (CML) Day takes place on September 22.
Leah SherwoodAcute Myeloid Leukemia | September 22, 2022
Guillermo Garcia-Manero, MD, gives his perspective.
Kerri FitzgeraldAcute Lymphoblastic Leukemia | September 19, 2022
September is Blood Cancer Awareness Month.
Leah SherwoodAcute Lymphoblastic Leukemia | August 8, 2022
Advances have been accomplished in the management of adults with acute lymphoblastic leukemia...
Kerri FitzgeraldMyeloproliferative Neoplasms | June 23, 2022
Pankit J. Vachhani, MD, and Srdan Verstovsek, MD, debate the usefulness of variant allele frequency (VAF).
Kerri FitzgeraldMyeloma | May 24, 2022
Peter M. Voorhees, MD, of the Levine Cancer Institute at Atrium Health, and Thomas Martin, MD, of the University of ...
Leah LawrenceMyeloma | May 5, 2022
Few patients with myeloma benefit from CAR-T cell therapy, according to a Viewpoint.
Leah LawrenceTransplantation & Cellular Therapy | March 2, 2022
With increasing evidence of efficacy as front-line treatment in relapsed/refractory disease, clinicians are excited to see ...
Sagar Lonial, MD, FACPMyeloma | March 2, 2022
Welcome to the second issue of Blood Cancers Today, where we’re continuing to share stories and updates on data that ...
Jeffrey Lancet, MDAcute Myeloid Leukemia | March 2, 2022
Jeffrey Lancet, MD, of Moffitt Cancer Center, reflects on the mentorship that helped him through a career crossroads.
Jacob Laubach, MD, MPPMyeloma | February 24, 2022
Jacob Laubach, MD, MPP, from Dana-Farber Cancer Institute, shares his thoughts.
Sagar Lonial, MD, FACPMyeloma | February 2, 2022
Editor-in-Chief Sagar Lonial, MD, FACP, introduces the new publication from SOHO.
Leah LawrenceAcute Lymphoblastic Leukemia | February 1, 2022
Decades in the making, information on measurable residual disease can greatly affect therapeutic decision making in ALL.
Sagar Lonial, MD, FACPMyeloma | January 21, 2022
The pace of change in blood cancers is quite dramatic, and new paradigms of treatment, assessment, and pathogenesis occur ...
Farhad Ravandi, MDAcute Myeloid Leukemia | January 21, 2022
Farhad Ravandi, MD, and Jeffrey Lancet, MD, squared off on this clinical quandary.
Kami Maddocks, MDAggressive B-Cell Lymphoma | January 20, 2022
Dr. Maddocks reflects on her small-town upbringing and learning to love triathlons.
Advertisement
Editorial Board

Advertisement